
Hikal Ltd Files FY26 Business Responsibility and Sustainability Report
Hikal Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as required by SEBI regulations. The report, which forms part of the Annual Report, details the company's ESG performance on a consolidated basis. Key disclosures include its business activities in pharmaceuticals, animal health, crop protection, and specialty chemicals, contributing 100% to turnover. The company operates 6 manufacturing facilities and 3 R&T centers in India, with international offices in Japan, USA, and representation in Europe. Exports constitute 69% of total turnover. The report also outlines employee details, including a workforce of 2077 employees and 1056 workers, with specific data on differently-abled personnel. Sustain Right provided reasonable assurance for the BRSR Core assessment.
Key Highlights
- Hikal Ltd filed its FY26 Business Responsibility and Sustainability Report.
- Report covers consolidated ESG performance across its business segments.
- Exports contribute significantly at 69% of total turnover.
- Company operates 6 manufacturing facilities and 3 R&T centers in India.
- BRSR Core assessment received reasonable assurance from Sustain Right.
Price Impact
More from HIKAL